Correlation Between AstraZeneca PLC and Safello Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Safello Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Safello Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC and Safello Group AB, you can compare the effects of market volatilities on AstraZeneca PLC and Safello Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Safello Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Safello Group.

Diversification Opportunities for AstraZeneca PLC and Safello Group

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AstraZeneca and Safello is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Safello Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Safello Group AB and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Safello Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Safello Group AB has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Safello Group go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Safello Group

Assuming the 90 days trading horizon AstraZeneca PLC is expected to under-perform the Safello Group. But the stock apears to be less risky and, when comparing its historical volatility, AstraZeneca PLC is 3.23 times less risky than Safello Group. The stock trades about -0.06 of its potential returns per unit of risk. The Safello Group AB is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  510.00  in Safello Group AB on September 1, 2024 and sell it today you would earn a total of  92.00  from holding Safello Group AB or generate 18.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC  vs.  Safello Group AB

 Performance 
       Timeline  
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Safello Group AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Safello Group AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Safello Group unveiled solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC and Safello Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Safello Group

The main advantage of trading using opposite AstraZeneca PLC and Safello Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Safello Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Safello Group will offset losses from the drop in Safello Group's long position.
The idea behind AstraZeneca PLC and Safello Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes